Biosimilars and the Patient Protection and Affordable Care Act: Where do we stand?
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2011 AND VI 46 AND IP 11
Results: 19
1
2
Drug Watch. Epilepsy and Parkinson's disease.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 504
- Publication type:
- Article
3
Policy Watch. Drug shortages challenge the healthcare community, FDA, and pharmaceutical manufacturers.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 503
- By:
- Publication type:
- Article
4
Meeting Coverage. Decision-makers urged to put personalized medicine into action.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 502
- By:
- Publication type:
- Article
5
Meeting Coverage. Specialty drug category grows with new approvals.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 502
- By:
- Publication type:
- Article
6
Medication Safety and Reliability. FDA warns methylene blue, linezolid may cause serotonin syndrome when co-administered with certain psychiatric medications.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 501
- Publication type:
- Article
7
Medication Safety and Reliability. FDA requires several changes to bevacizumab label to include safety information.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 504
- Publication type:
- Article
8
Anticoagulation prophylaxis practice patterns in patients having total hip, total knee replacement in a US health plan.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 486
- By:
- Publication type:
- Article
9
Better medication adherence leads to better outcomes in hepatitis C.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 457
- Publication type:
- Article
10
Switching patients from IV to oral form of drugs could save millions, reduce adverse events.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 459
- Publication type:
- Article
11
Creative contracting initiatives key for pharma as competition in RA market increases.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 458
- By:
- Publication type:
- Article
12
Rosato appointed new AMCP CEO.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 458
- By:
- Publication type:
- Article
13
Removing anthracyclines from HER2-positive breast cancer treatment reduces cardiac toxicity.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 457
- Publication type:
- Article
14
Crizotinib: A novel, targeted gene therapy for the treatment of non-small-cell lung cancer.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 460
- By:
- Publication type:
- Article
15
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 456
- Publication type:
- Article
16
FDA Drug Approvals. First-time generic approvals.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 456
- Publication type:
- Article
17
FDA Drug Approvals. New formulation.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 455
- Publication type:
- Article
18
FDA Drug Approvals. New molecular entity.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 455
- Publication type:
- Article
19
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2011, v. 46, n. 11, p. 455
- Publication type:
- Article